Pacemaker syndrome: Difference between revisions

Jump to navigation Jump to search
Line 26: Line 26:


===Increased Production of Natriuretic Peptides===
===Increased Production of Natriuretic Peptides===
{{main|atrial natriuretic peptide}}
{{main|Atrial natriuretic peptide}}
{{main|brain natriuretic peptide}}
{{main|Brain natriuretic peptide}}
 
Patients with [[artificial pacemaker|pacemaker]] [[syndrome]] exhibit increased plasma levels of [[atrial natriuretic peptide|ANP]]. That's due to increase in [[left atrium|left atrial]] pressure and [[left ventricle|left ventricular]] filling pressure, which is due to decreased [[cardiac output]] caused by dyssynchrony in [[atrium (heart)|atrial]] and [[ventricle (heart)|ventricular]] contraction. [[atrial natriuretic peptide|ANP]] and [[brain natriuretic peptide|BNP]] are potent [[artery|arterial]] and [[vein|venous]] [[vasodilation|vasodilators]] that can override [[common carotid artery|carotid]] and [[aorta|aortic]] [[baroreflex|baroreceptor reflex]]es attempting to compensate for decreased [[blood pressure]]. Usually patients with [[cannon A waves|cannon a waves]] have higher plasma levels of [[atrial natriuretic peptide|ANP]] than those without [[cannon A waves|cannon a waves]].<ref name="pmid9164889"/><ref name="pmid9036762">{{cite journal |author=Theodorakis GN, Panou F, Markianos M, Fragakis N, Livanis EG, Kremastinos DT |title=Left atrial function and atrial natriuretic factor/cyclic guanosine monophosphate changes in DDD and VVI pacing modes |journal=Am. J. Cardiol. |volume=79 |issue=3 |pages=366–70 |year=1997 |month=February |pmid=9036762 |url=http://linkinghub.elsevier.com/retrieve/pii/S0002914997892855 |doi=10.1016/S0002-9149(97)89285-5}}</ref><ref name="pmid1334465">{{cite journal |author=Theodorakis GN, Kremastinos DT, Markianos M, Livanis E, Karavolias G, Toutouzas PK |title=Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise |journal=Eur. Heart J. |volume=13 |issue=11 |pages=1477–81 |year=1992 |month=November |pmid=1334465 |doi= |url=http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=1334465}}</ref>
Patients with [[artificial pacemaker|pacemaker]] [[syndrome]] exhibit increased plasma levels of [[atrial natriuretic peptide|ANP]]. That's due to increase in [[left atrium|left atrial]] pressure and [[left ventricle|left ventricular]] filling pressure, which is due to decreased [[cardiac output]] caused by dyssynchrony in [[atrium (heart)|atrial]] and [[ventricle (heart)|ventricular]] contraction. [[atrial natriuretic peptide|ANP]] and [[brain natriuretic peptide|BNP]] are potent [[artery|arterial]] and [[vein|venous]] [[vasodilation|vasodilators]] that can override [[common carotid artery|carotid]] and [[aorta|aortic]] [[baroreflex|baroreceptor reflex]]es attempting to compensate for decreased [[blood pressure]]. Usually patients with [[cannon A waves|cannon a waves]] have higher plasma levels of [[atrial natriuretic peptide|ANP]] than those without [[cannon A waves|cannon a waves]].<ref name="pmid9164889"/><ref name="pmid9036762">{{cite journal |author=Theodorakis GN, Panou F, Markianos M, Fragakis N, Livanis EG, Kremastinos DT |title=Left atrial function and atrial natriuretic factor/cyclic guanosine monophosphate changes in DDD and VVI pacing modes |journal=Am. J. Cardiol. |volume=79 |issue=3 |pages=366–70 |year=1997 |month=February |pmid=9036762 |url=http://linkinghub.elsevier.com/retrieve/pii/S0002914997892855 |doi=10.1016/S0002-9149(97)89285-5}}</ref><ref name="pmid1334465">{{cite journal |author=Theodorakis GN, Kremastinos DT, Markianos M, Livanis E, Karavolias G, Toutouzas PK |title=Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise |journal=Eur. Heart J. |volume=13 |issue=11 |pages=1477–81 |year=1992 |month=November |pmid=1334465 |doi= |url=http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=1334465}}</ref>



Revision as of 19:59, 8 February 2013

Pacemaker syndrome

WikiDoc Resources for Pacemaker syndrome

Articles

Most recent articles on Pacemaker syndrome

Most cited articles on Pacemaker syndrome

Review articles on Pacemaker syndrome

Articles on Pacemaker syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pacemaker syndrome

Images of Pacemaker syndrome

Photos of Pacemaker syndrome

Podcasts & MP3s on Pacemaker syndrome

Videos on Pacemaker syndrome

Evidence Based Medicine

Cochrane Collaboration on Pacemaker syndrome

Bandolier on Pacemaker syndrome

TRIP on Pacemaker syndrome

Clinical Trials

Ongoing Trials on Pacemaker syndrome at Clinical Trials.gov

Trial results on Pacemaker syndrome

Clinical Trials on Pacemaker syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pacemaker syndrome

NICE Guidance on Pacemaker syndrome

NHS PRODIGY Guidance

FDA on Pacemaker syndrome

CDC on Pacemaker syndrome

Books

Books on Pacemaker syndrome

News

Pacemaker syndrome in the news

Be alerted to news on Pacemaker syndrome

News trends on Pacemaker syndrome

Commentary

Blogs on Pacemaker syndrome

Definitions

Definitions of Pacemaker syndrome

Patient Resources / Community

Patient resources on Pacemaker syndrome

Discussion groups on Pacemaker syndrome

Patient Handouts on Pacemaker syndrome

Directions to Hospitals Treating Pacemaker syndrome

Risk calculators and risk factors for Pacemaker syndrome

Healthcare Provider Resources

Symptoms of Pacemaker syndrome

Causes & Risk Factors for Pacemaker syndrome

Diagnostic studies for Pacemaker syndrome

Treatment of Pacemaker syndrome

Continuing Medical Education (CME)

CME Programs on Pacemaker syndrome

International

Pacemaker syndrome en Espanol

Pacemaker syndrome en Francais

Business

Pacemaker syndrome in the Marketplace

Patents on Pacemaker syndrome

Experimental / Informatics

List of terms related to Pacemaker syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Pacemaker syndrome is a disease that represents the clinical consequences of suboptimal atrioventricular (AV) synchrony or AV dyssynchrony, regardless of the pacing mode, after the pacemaker plantation.[1][2]. It is an iatrogenic disease that is often underdiagnosed[1][3]. In general, the symptoms of the syndrome are a combination of decreased cardiac output, loss of atrial contribution to ventricular filling, loss of total peripheral resistance response, and nonphysiologic pressure waves.[2][4][5]

Individuals with a low heart rate prior to pacemaker implantation are more at risk of developing pacemaker syndrome. Normally the first chamber of the heart (atrium) contracts as the second chamber (ventricle) is relaxed, allowing the ventricle to fill before it contracts and pumps blood out of the heart. When the timing between the two chambers goes out of synchronization, less blood is delivered on each beat. Patients who develop pacemaker syndrome may require adjustment of the pacemaker timing, or another lead fitted to regulate the timing of the chambers separately.

Pathophysiology

The loss of physiologic timing of atrial and ventricular contractions, or sometimes called AV dyssynchrony, leads to different mechanisms of symptoms production. This altered ventricular contraction will decrease cardiac output, and in turn will lead to systemic hypotensive reflex response with varying symptoms.[1][2][4][5]

Loss of Atrial Contraction

Inappropriate pacing in patients with decreased ventricular compliance, which may be caused by diseases such as hypertensive cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and aging, can result in loss of atrial contraction and significantly reduces cardiac output. Because in such cases the atrias are required to provide 50% of cardiac output, which normally provides only 15% - 25% of cardiac output.[6][7]

Cannon A Waves

Atrial contraction against a closed tricuspid valve can cause pulsation in the neck and abdomen, headache, cough, and jaw pain.[6][8]

Increased Atrial Pressure

Ventricular pacing is associated with elevated right and left atrial pressures, as well as elevated pulmonary venous and pulmonary arterial pressures, which can lead to symptomatic pulmonary and hepatic congestion.[5]

Increased Production of Natriuretic Peptides

Patients with pacemaker syndrome exhibit increased plasma levels of ANP. That's due to increase in left atrial pressure and left ventricular filling pressure, which is due to decreased cardiac output caused by dyssynchrony in atrial and ventricular contraction. ANP and BNP are potent arterial and venous vasodilators that can override carotid and aortic baroreceptor reflexes attempting to compensate for decreased blood pressure. Usually patients with cannon a waves have higher plasma levels of ANP than those without cannon a waves.[1][9][10]

VA Conduction

A major cause of AV dyssynchrony is VA conduction. VA conduction, sometimes referred to as retrograde conduction, leads to delayed, nonphysiologic timing of atrial contraction in relation to ventricular contraction. Nevertheless, many conditions other than VA conduction promote AV dyssynchrony.[1][2][4][6][8]

This will further decrease blood pressure, and secondary increase in ANP and BNP.[9][10]

Risk Factors

  • In the pre-implantation period, two variables are predicted to predispose to the syndrome. First is low sinus rate, and second is a higher programmed lower rate limit. In post-implantation, an increased percentage of ventricular paced beats is the only variable that significantly predicts development of pacemaker syndrome.
  • Patients with intact VA conduction are at greater risk for developing pacemaker syndrome. Around 90% of patients with preserved AV conduction have intact VA conduction, and about 30-40% of patients with complete AV block have preserved VA conduction. Intact VA conduction may not be apparent at the time of pacemaker implantation or even may develop at any time after implantation.[11]

References

  1. 1.0 1.1 1.2 1.3 1.4 Ellenbogen KA, Gilligan DM, Wood MA, Morillo C, Barold SS (1997). "The pacemaker syndrome -- a matter of definition". Am. J. Cardiol. 79 (9): 1226–9. doi:10.1016/S0002-9149(97)00085-4. PMID 9164889. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 2.2 2.3 Chalvidan T, Deharo JC, Djiane P (2000). "[Pacemaker syndromes]". Ann Cardiol Angeiol (Paris) (in French). 49 (4): 224–9. PMID 12555483. Unknown parameter |month= ignored (help)
  3. Baumgartner, William A.; Yuh, David D.; Luca A. Vricella (2007). The Johns Hopkins manual of cardiothoracic surgery. New York: McGraw-Hill Medical Pub. ISBN 0-07-141652-8.
  4. 4.0 4.1 4.2 Frielingsdorf J, Gerber AE, Hess OM (1994). "Importance of maintained atrio-ventricular synchrony in patients with pacemakers". Eur. Heart J. 15 (10): 1431–40. PMID 7821326. Unknown parameter |month= ignored (help)
  5. 5.0 5.1 5.2 Furman S (1994). "Pacemaker syndrome". Pacing Clin Electrophysiol. 17 (1): 1–5. doi:10.1111/j.1540-8159.1994.tb01342.x. PMID 7511223. Unknown parameter |month= ignored (help)
  6. 6.0 6.1 6.2 Petersen HH, Videbaek J (1992). "[The pacemaker syndrome]". Ugeskr. Laeg. (in Danish). 154 (38): 2547–51. PMID 1413181. Unknown parameter |month= ignored (help)
  7. Gross JN, Keltz TN, Cooper JA, Breitbart S, Furman S (1992). "Profound "pacemaker syndrome" in hypertrophic cardiomyopathy". Am. J. Cardiol. 70 (18): 1507–11. doi:10.1016/0002-9149(92)90313-N. PMID 1442632. Unknown parameter |month= ignored (help)[dead link]
  8. 8.0 8.1 Schüller H, Brandt J (1991). "The pacemaker syndrome: old and new causes". Clin Cardiol. 14 (4): 336–40. doi:10.1002/clc.4960140410. PMID 2032410. Unknown parameter |month= ignored (help)
  9. 9.0 9.1 Theodorakis GN, Panou F, Markianos M, Fragakis N, Livanis EG, Kremastinos DT (1997). "Left atrial function and atrial natriuretic factor/cyclic guanosine monophosphate changes in DDD and VVI pacing modes". Am. J. Cardiol. 79 (3): 366–70. doi:10.1016/S0002-9149(97)89285-5. PMID 9036762. Unknown parameter |month= ignored (help)
  10. 10.0 10.1 Theodorakis GN, Kremastinos DT, Markianos M, Livanis E, Karavolias G, Toutouzas PK (1992). "Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise". Eur. Heart J. 13 (11): 1477–81. PMID 1334465. Unknown parameter |month= ignored (help)
  11. Heldman D, Mulvihill D, Nguyen H; et al. (1990). "True incidence of pacemaker syndrome". Pacing Clin Electrophysiol. 13 (12 Pt 2): 1742–50. doi:10.1111/j.1540-8159.1990.tb06883.x. PMID 1704534. Unknown parameter |month= ignored (help)

Template:WH Template:WS